Vimarsana
Biggest News Aggregation in the World

Page 4 - Cms Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cms Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cms Center Today - Breaking & Trending Today

Stem Cell Transplants: Overhyped, But One Huge Benefit May Be Close - Vimarsana News

Stem Cell Transplants: Overhyped, But One Huge Benefit May Be Close

Although the theoretical applications for stem cell research are seemingly endless, the far-off possibilities are not as awe-inspiring as some scientists would like. Setbacks, ethical concerns and funding are all part of the hurdles that face all new scientific research, stem cell research especially.

Op-ed | Support care and hope during MS Awareness Week - Vimarsana News

Op-ed | Support care and hope during MS Awareness Week

Nearly one million people in the United States are living with Multiple Sclerosis (MS). I am one of them.

Source: amny.com
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple ... - Vimarsana News

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple ...

NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3

Multiple sclerosis: Stem cell therapy shows promise in trial - Vimarsana News

Multiple sclerosis: Stem cell therapy shows promise in trial

An early clinical trial looking at stem cell therapy for progressive multiple sclerosis suggests that it could halt the progression of motor disability and cognitive impairment.

Autonomic Dysfunction Significantly Associated With Decreased Quality of Life in MS, NMOSD - Vimarsana News

Autonomic Dysfunction Significantly Associated With Decreased Quality of Life in MS, NMOSD

Findings showed that autonomic symptom burden was slightly more severe in patients with multiple sclerosis (MS) compared with those with NMOSD, although the difference was not statistically significant.

Source: ajmc.com